{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:41:06Z","timestamp":1790372466782,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974377"],"award-info":[{"award-number":["81974377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/20200128"],"award-info":[{"award-number":["2023JH2\/20200128"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00802-7","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:24:47Z","timestamp":1776529487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The B7 family subgroup reflects tumor cell heterogeneity and patient post-operative prognosis in gallbladder cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Chuhan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YunHao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanhao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"802_CR1","doi-asserted-by":"crossref","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Reviews Disease Primers. 2022;8(1).","DOI":"10.1038\/s41572-022-00398-y"},{"issue":"1","key":"802_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cam4.2679","volume":"9","author":"W Mao","year":"2019","unstructured":"Mao W, Deng F, Wang D, Gao L, Shi X. Treatment of advanced gallbladder cancer: A SEER-based study. Cancer Med. 2019;9(1):141\u201350.","journal-title":"Cancer Med"},{"issue":"6","key":"802_CR3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.suc.2024.03.006","volume":"104","author":"GC Waller","year":"2024","unstructured":"Waller GC, Sarpel U. Gallbladder Cancer. Surg Clin North Am. 2024;104(6):1263\u201380.","journal-title":"Surg Clin North Am"},{"issue":"8","key":"802_CR4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K, Metastasis. Cell. 2023;186(8):1564\u201379.","journal-title":"Cell"},{"issue":"10","key":"802_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41419-024-07171-x","volume":"15","author":"RN Sugiyanto","year":"2024","unstructured":"Sugiyanto RN, Metzger C, Inal A, et al. Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT\/ERK signaling. Cell Death Dis. 2024;15(10):780.","journal-title":"Cell Death Dis"},{"issue":"1","key":"802_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12967-024-05091-0","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li H, Liu K, et al. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis. J Transl Med. 2024;22(1):299.","journal-title":"J Transl Med"},{"issue":"1","key":"802_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41419-025-07372-y","volume":"16","author":"Z Wu","year":"2025","unstructured":"Wu Z, Peng Y, Chen W, Xia F, Song T, Ke Q. Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination. Cell Death Dis. 2025;16(1):144.","journal-title":"Cell Death Dis"},{"issue":"2","key":"802_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"Cancer J Clin"},{"key":"802_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejrad.2018.11.034","volume":"110","author":"EAJ de Savornin Lohman","year":"2019","unstructured":"de Savornin Lohman EAJ, de Bitter TJJ, van Laarhoven CJHM, Hermans JJ, de Haas RJ, de Reuver PR. The diagnostic accuracy of CT and MRI for the detection of lymph node metastases in gallbladder cancer: A systematic review and meta-analysis. Eur J Radiol. 2019;110:156\u201362.","journal-title":"Eur J Radiol"},{"issue":"3","key":"802_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.semdp.2012.08.010","volume":"29","author":"NV Adsay","year":"2012","unstructured":"Adsay NV, Bagci P, Tajiri T, et al. Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC\/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol. 2012;29(3):127\u201341.","journal-title":"Semin Diagn Pathol"},{"issue":"17","key":"802_CR11","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/cncr.35243","volume":"130","author":"SP Patel","year":"2024","unstructured":"Patel SP, Guadarrama E, Chae YK, et al. SWOG 1609 cohort 48: anti\u2013CTLA-4 and anti\u2013PD\u20101 for advanced gallbladder cancer. Cancer. 2024;130(17):2918\u201327.","journal-title":"Cancer"},{"key":"802_CR12","doi-asserted-by":"crossref","unstructured":"Wu T, Pu C, Wang Q, Zhang K. Comparison of efficacy and safety of anti-programmed cell death-1 antibody plus lenvatinib and chemotherapy as first-line therapy for patients with stage IV gallbladder cancer: a real-world study in a Chinese population. Biomedicines. 2023;11(11).","DOI":"10.3390\/biomedicines11112933"},{"issue":"1","key":"802_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-024-04905-5","volume":"22","author":"X He","year":"2024","unstructured":"He X, Peng Y, He G, et al. Correction to: Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer. J Transl Med. 2024;22(1):118.","journal-title":"J Transl Med"},{"key":"802_CR14","doi-asserted-by":"crossref","unstructured":"Song X, Hu Y, Li Y, Shao R, Liu F, Liu Y. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Therapy. 2020;5(1).","DOI":"10.1038\/s41392-020-00324-2"},{"issue":"1","key":"802_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imr.12521","volume":"276","author":"M Janakiram","year":"2017","unstructured":"Janakiram M, Shah UA, Liu W, Zhao A, Schoenberg MP, Zang X. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7\u2010H3. Immunol Rev. 2017;276(1):26\u201339.","journal-title":"Immunol Rev"},{"key":"802_CR16","doi-asserted-by":"crossref","unstructured":"Lv C, Han S, Wu B, et al. Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.984172"},{"key":"802_CR17","doi-asserted-by":"crossref","unstructured":"Shi X, Li Z, Yao R, et al. Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment. NPJ Precision Oncol. 2022;6(1).","DOI":"10.1038\/s41698-022-00300-9"},{"key":"802_CR18","doi-asserted-by":"crossref","unstructured":"Wang JH, Zhao LF, Wang HF, et al. GenCLiP 3: mining human genes\u2019 functions and regulatory networks from PubMed based on co-occurrences and natural language processing. Bioinformatics. 2019.","DOI":"10.1093\/bioinformatics\/btz807"},{"issue":"13\u201314","key":"802_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.spl.2010.02.020","volume":"80","author":"H Ishwaran","year":"2010","unstructured":"Ishwaran H, Kogalur UB. Consistency of random survival forests. Stat Probab Lett. 2010;80(13\u201314):1056\u201364.","journal-title":"Stat Probab Lett"},{"key":"802_CR20","doi-asserted-by":"crossref","unstructured":"Natekin A, Knoll A. Gradient boosting machines, a tutorial. Front Neurorobotics. 2013;7.","DOI":"10.3389\/fnbot.2013.00021"},{"issue":"5","key":"802_CR21","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/S1470-2045(19)30149-4","volume":"20","author":"KY Ngiam","year":"2019","unstructured":"Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262\u201373.","journal-title":"Lancet Oncol"},{"key":"802_CR22","doi-asserted-by":"crossref","unstructured":"Kaur I, Doja MN, Ahmad T. Data mining and machine learning in cancer survival research: an overview and future recommendations. J Biomed Inform. 2022;128.","DOI":"10.1016\/j.jbi.2022.104026"},{"key":"802_CR23","doi-asserted-by":"crossref","unstructured":"Chen P, Li Y, Yang C, Zhang Q. Machine learning models integrating dietary data predict all-cause mortality in U.S. NAFLD patients: an NHANES-based study. Nutr J. 2025;24(1).","DOI":"10.1186\/s12937-025-01170-0"},{"issue":"10","key":"802_CR24","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1111\/cas.70149","volume":"116","author":"J Zhang","year":"2025","unstructured":"Zhang J, Pan J, Lin J, et al. Prognostic and Predictive Value of Machine Learning-Based Biomarker and Pathomics Signatures in Patients With Prostate Cancer. Cancer Sci. 2025;116(10):2893\u2013906.","journal-title":"Cancer Sci"},{"issue":"10","key":"802_CR25","doi-asserted-by":"publisher","first-page":"a011197","DOI":"10.1101\/cshperspect.a011197","volume":"5","author":"JL Wrana","year":"2013","unstructured":"Wrana JL. Signaling by the TGFbeta superfamily. Cold Spring Harb Perspect Biol. 2013;5(10):a011197.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"802_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"12","key":"802_CR27","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1038\/s41596-023-00892-x","volume":"18","author":"JAI Johnson","year":"2023","unstructured":"Johnson JAI, Tsang AP, Mitchell JT, et al. Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R and GenePattern Notebook implementations of CoGAPS. Nat Protoc. 2023;18(12):3690\u2013731.","journal-title":"Nat Protoc"},{"issue":"30","key":"802_CR28","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1002\/sim.9934","volume":"42","author":"Y Cai","year":"2023","unstructured":"Cai Y, Gu H, Kenney T. Rank selection for non-negative matrix factorization. Stat Med. 2023;42(30):5676\u201393.","journal-title":"Stat Med"},{"key":"802_CR29","doi-asserted-by":"crossref","unstructured":"Ma C, Hu H, Li H, Han B, Lv C, Tian Y. Extracellular matrix remodeling fibroblasts govern the tumor microenvironment disparity between adenomatous lesions and adenocarcinoma in gallbladder. Front Immunol. 2025;16.","DOI":"10.3389\/fimmu.2025.1637300"},{"key":"802_CR30","doi-asserted-by":"crossref","unstructured":"Wu B, Zhong C, Lang Q et al. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy. J Experimental Clin Cancer Res. 2021;40(1).","DOI":"10.1186\/s13046-021-02068-5"},{"key":"802_CR31","doi-asserted-by":"crossref","unstructured":"Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1212476"},{"issue":"1","key":"802_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2019","unstructured":"Kalbasi A, Ribas A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol. 2019;20(1):25\u201339.","journal-title":"Nat Rev Immunol"},{"key":"802_CR33","doi-asserted-by":"crossref","unstructured":"Ma C, Li Y, Li M, Lv C, Tian Y. Targeting immune checkpoints on myeloid cells: current status and future directions. Cancer Immunol Immunother. 2025;74(2).","DOI":"10.1007\/s00262-024-03856-6"},{"issue":"2","key":"802_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.immuni.2024.01.013","volume":"57","author":"KP Burke","year":"2024","unstructured":"Burke KP, Chaudhri A, Freeman GJ, Sharpe AH. The B7:CD28 family and friends: Unraveling coinhibitory interactions. Immunity. 2024;57(2):223\u201344.","journal-title":"Immunity"},{"issue":"5","key":"802_CR35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","volume":"27","author":"F Kontos","year":"2021","unstructured":"Kontos F, Michelakos T, Kurokawa T, et al. B7-H3: An Attractive Target for Antibody-based Immunotherapy. Clin Cancer Res. 2021;27(5):1227\u201335.","journal-title":"Clin Cancer Res"},{"key":"802_CR36","doi-asserted-by":"crossref","unstructured":"Getu AA, Tigabu A, Zhou M, Lu J, Fodstad \u00d8, Tan M. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol Cancer. 2023;22(1).","DOI":"10.1186\/s12943-023-01751-9"},{"issue":"11","key":"802_CR37","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.jtho.2023.09.042","volume":"18","author":"M Johnson","year":"2023","unstructured":"Johnson M, Awad M, Koyama T, et al. OA05.05 Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1\/2 Study. J Thorac Oncol. 2023;18(11):S54\u20135.","journal-title":"J Thorac Oncol"},{"key":"802_CR38","doi-asserted-by":"crossref","unstructured":"Dawidowicz M, Kot A, Mielcarska S, et al. B7H4 role in solid cancers: a review of the literature. Cancers. 2024;16(14).","DOI":"10.3390\/cancers16142519"},{"key":"802_CR39","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1016\/j.annonc.2023.09.1846","volume":"34","author":"CA Perez","year":"2023","unstructured":"Perez CA, Henry JT, Lakhani N, et al. 660MO First-in-human study of SGN-B7H4V, a B7-H4-directed vedotin ADC, in patients with advanced solid tumors: Preliminary results of a phase I study (SGNB7H4V-001). Ann Oncol. 2023;34:S464\u20135.","journal-title":"Ann Oncol"},{"key":"802_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jare.2022.07.013","volume":"47","author":"Y Li","year":"2023","unstructured":"Li Y, Lv C, Yu Y, et al. KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy. J Adv Res. 2023;47:137\u201350.","journal-title":"J Adv Res"},{"key":"802_CR41","doi-asserted-by":"crossref","unstructured":"Tian Y, Sun Y, Gao F, et al. CD28H expression identifies resident memory CD8\u2009+\u2009T cells with less cytotoxicity in human peripheral tissues and cancers. OncoImmunology. 2018;8(2).","DOI":"10.1080\/2162402X.2018.1538440"},{"issue":"6","key":"802_CR42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.trecan.2025.02.007","volume":"11","author":"Y Luo","year":"2025","unstructured":"Luo Y, Yuan Y, Liu D, Peng H, Shen L, Chen Y. Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside. Trends Cancer. 2025;11(6):540\u201359.","journal-title":"Trends Cancer"},{"issue":"16","key":"802_CR43","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1097\/CM9.0000000000002772","volume":"136","author":"L Xia","year":"2023","unstructured":"Xia L, Chen Y, Li J, et al. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT\/pAKT\/Nrf2 pathway. Chin Med J. 2023;136(16):1977\u201389.","journal-title":"Chin Med J"},{"key":"802_CR44","doi-asserted-by":"crossref","unstructured":"Liao H, Ding M, Zhou N, Yang Y, Chen L. B7\u2013H3 promotes the epithelial\u2013mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K\/AKT pathway. Mol Med Rep. 2022;25(3).","DOI":"10.3892\/mmr.2022.12595"},{"key":"802_CR45","doi-asserted-by":"crossref","unstructured":"Kang F-b, Wang L, Jia H-c, et al. Correction to: B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2\/STAT3\/Slug signaling pathway. Cancer Cell Int. 2021;21(1).","DOI":"10.1186\/s12935-021-02216-z"},{"key":"802_CR46","doi-asserted-by":"crossref","unstructured":"Sutton MN, Glazer SE, Muzzioli R, Yang P, Gammon ST, Piwnica-Worms D. Dimerization of the 4Ig isoform of B7-H3 in tumor cells mediates enhanced proliferation and tumorigenic signaling. Commun Biology. 2024;7(1).","DOI":"10.1038\/s42003-023-05736-8"},{"key":"802_CR47","doi-asserted-by":"crossref","unstructured":"Xie N, Cai J-B, Zhang L, et al. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Cell Death Dis. 2017;8(12).","DOI":"10.1038\/s41419-017-0015-6"},{"issue":"7","key":"802_CR48","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/cas.12949","volume":"107","author":"X Chen","year":"2016","unstructured":"Chen X, Wang L, Wang W, Zhao L, Shan B. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin\u20106\/signal transducer and activator of transcription 3 pathway activation. Cancer Sci. 2016;107(7):944\u201354.","journal-title":"Cancer Sci"},{"issue":"1","key":"802_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/21655979.2021.2009411","volume":"13","author":"Y Yin","year":"2021","unstructured":"Yin Y, Shi L, Yang J, Wang H, Yang H, Wang Q. B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells. Bioengineered. 2021;13(1):107\u201318.","journal-title":"Bioengineered"},{"key":"802_CR50","doi-asserted-by":"crossref","unstructured":"Yu L, Ji Kim H, Kim B, et al. Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway. Biochem Pharmacol. 2023;212.","DOI":"10.1016\/j.bcp.2023.115537"},{"issue":"4","key":"802_CR51","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s10753-022-01644-x","volume":"45","author":"H Guo","year":"2022","unstructured":"Guo H, Zhang C, Tang X, et al. HHLA2 Activates the JAK\/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells. Inflammation. 2022;45(4):1585\u201399.","journal-title":"Inflammation"},{"issue":"7","key":"802_CR52","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/mc.23723","volume":"63","author":"J Wang","year":"2024","unstructured":"Wang J, Yang K, Yang X, et al. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1\/PI3K\/AKT signaling pathway. Mol Carcinog. 2024;63(7):1275\u201387.","journal-title":"Mol Carcinog"},{"key":"802_CR53","doi-asserted-by":"crossref","unstructured":"Fu Y, Zheng P, Zheng X, et al. Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-\u03baB signaling pathway and suppresses the expression of CA9. Cell Immunol. 2023;388\u20139.","DOI":"10.1016\/j.cellimm.2023.104730"},{"key":"802_CR54","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li H, Lv C, et al. HHLA2 promotes tumor progression by long non\u2013coding RNA H19 in human gallbladder cancer. Int J Oncol. 2022;61(3).","DOI":"10.3892\/ijo.2022.5402"},{"issue":"1","key":"802_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, et al. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11(1):244.","journal-title":"Cell Death Discov"},{"issue":"1","key":"802_CR56","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, et al. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J Transl Med. 2025;23(1):581.","journal-title":"J Transl Med"},{"issue":"1","key":"802_CR57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, et al. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell Death Discov. 2024;10(1):198.","journal-title":"Cell Death Discov"},{"issue":"5","key":"802_CR58","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529.","journal-title":"Genes Dis"},{"issue":"1","key":"802_CR59","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2026","unstructured":"Liu C, Wang S, Zhang X, et al. The biomechanical signature of tumor invasion. Genes Dis. 2026;13(1):101771.","journal-title":"Genes Dis"},{"issue":"1","key":"802_CR60","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, et al. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J Transl Med. 2025;23(1):548.","journal-title":"J Transl Med"},{"issue":"1","key":"802_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J Transl Med. 2025;23(1):340.","journal-title":"J Transl Med"},{"issue":"1","key":"802_CR62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-beta signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov. 2025;11(1):262.","journal-title":"Cell Death Discov"},{"key":"802_CR63","doi-asserted-by":"crossref","unstructured":"Bailly C, Beignet J, Loirand G, Sauzeau V. Rac1 as a therapeutic anticancer target: promises and limitations. Biochem Pharmacol. 2022;203.","DOI":"10.1016\/j.bcp.2022.115180"},{"issue":"12","key":"802_CR64","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-18-0619","volume":"78","author":"MDM Maldonado","year":"2018","unstructured":"Maldonado MDM, Dharmawardhane S. Targeting Rac and Cdc42 GTPases in Cancer. Cancer Res. 2018;78(12):3101\u201311.","journal-title":"Cancer Res"},{"key":"802_CR65","doi-asserted-by":"crossref","unstructured":"Chu X, Tian W, Wang Z, Zhang J, Zhou R. Co-inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials. Mol Cancer. 2023;22(1).","DOI":"10.1186\/s12943-023-01800-3"},{"key":"802_CR66","doi-asserted-by":"crossref","unstructured":"Wang F, Hao J, Wei K, et al. Comparative diagnostic efficacy and safety of ultrasound-guided percutaneous transhepatic biopsy and endoscopic ultrasound-guided fine-needle aspiration biopsy for gallbladder tumors. Sci Rep. 2025;15(1).","DOI":"10.1038\/s41598-025-87847-2"}],"updated-by":[{"DOI":"10.1186\/s13062-026-00925-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000}}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00802-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:42:38Z","timestamp":1788500558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00802-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00802-7","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13062-026-00925-x","URL":"https:\/\/doi.org\/10.1186\/s13062-026-00925-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Shengjing Hospital (2024PS710K) and was conducted respecting the Declaration of Helsinki. Each patient has signed an informed consent to participate in this research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants agreed to the publication of their data as part of the research results.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"84"}}